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he Intercontinental Cooperative Immune
Thrombocytopenia (ITP) Study Group (ICIS)
expert meetings in Switzerland are becoming
a tradition. The 4th expert meeting was held in
Montreux, Switzerland at the lake of Geneva in
September 2012, after successful meetings in
Bu¨rgenstock (2003), Yverdon (2006), and Basel
(2009). At each meeting, articles by attending experts
who served as chairmen and/or speakers were pub-
lished in medical journals, the first two meetings in
pediatric journals: Journal of Pediatric Hematology/
Oncology1 and Pediatric Blood & Cancer,2 at a time
when ICIS studied pediatric ITP. The third meeting in
Basel 2006 represented the start of a fruitful colla-
boration of pediatric and adult hematology, and the
ICIS ‘‘mutated’’ from a pediatric to a pediatric and
adult cooperative ITP study group. The Basel meeting
was published in Annals of Hematology.3
We are proud to have Seminars in Hematology as
host for the 4th ICIS Expert Meeting in Montreux. The
heading of the meeting was ‘‘Changes in Immune
Thrombocytopenia of Children and Adults.’’ There
were six seminars with two to three plenary sessions
and workshop meetings each: (1) ITP, unknown
etiology; (2) ITP: nomenclature, guidelines, and nat-
ural history; (3) ITP as a model of disturbed innate and
adaptive immunity and autoimmunity; (4) individua-
lized management approaches in ITP; (5) ITP as model
of platelet stimulatory factors; and (6) patient-related
outcome (PRO) measures in ITP. All speakers and
chairmen of seminars were invited to write an article
about their contribution. Additionally, workshop0037-196
& 2013 Published by Elsevier Inc.
http://dx.doi.org/10.1053/j.seminhematol.2013.03.001
Publication of this article was supported by the International Coop-
erative ITP Study Group (ICIS).
Conflicts of interest: none.
Seminars in Hematology, Vol 50, No 1, Suppl 1, January 2013, p
Open access under CC BY-NC-ND license.members were invited to summarize their discussions.
Twenty-one articles were submitted by internationally
well-known and distinguished experts. There are 12
speakers’ articles, three summary articles, and six
review articles. The manuscripts reflect well the
discussions at scientific sessions and workshops both
on basic and clinical research.
It has been realized that there is a remarkable gain of
knowledge of the various pathophysiological mechan-
isms of the heterogenous ‘‘disorder’’ ITP, and that
clinical research benefits from this wisdom. Moreover,
the increase in clinical randomized controlled trials
based on the advent of thrombopoietin mimetics is
remarkable and the international collaboration attempt-
ing to coordinate research and save resources is
amazing. Several practice guidelines were elaborated
and filled a gap, where evidence is lacking, standardiza-
tion activities were initiated, and international coordi-
nating groups were established. The ICIS is supporting
all of these activities since its founding year of 1997.
The ICIS meeting in Montreux is such an opportunity
to communicate research results, to network, to colla-
borate, and to coordinate, as resources are increasingly
limited, and as not all good ideas can be realized
immediately. We hope that readers get an impression
of the cooperative and scientific atmosphere of the
Montreux meeting and enjoy the excellent articles.
We thank all attending and actively participating
experts, speakers and workshop heads who did a great
job and made our meeting a success, and we thank all
contributors of this supplement to Seminars in Hema-
tology. We thank Verena Stahel, Monika Imbach, and
Caroline Martin our ICIS office staff at Basel, Switzerland
for organizing this meeting and for their enthusiasm. We
thank Aure´lien Reymond, events manager, and his
hotel staff of Hotel Eden Palace, Montreux for their
great support of our meeting, and the musicians for
their wonderful performances. Many thanks to ourp S1–S2 S1
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Fund, and the University Children’s Hospital Basel,
Amgen, CSL Behring, and GlaxoSmithKline.
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